Status:
RECRUITING
Effects of Topical Insulin on Corneal Epithelium Healing After Corneal Crosslinking in Patients With Keratoconus
Lead Sponsor:
University of Campinas, Brazil
Conditions:
Keratoconus
Cornea Disease
Eligibility:
All Genders
14+ years
Phase:
PHASE3
Brief Summary
The cornea plays a fundamental role in vision, being a complex tissue essential for ocular health. In ophthalmological practice, there are situations such as corneal crosslinking, where damage to the ...
Detailed Description
Patients from the Keratoconus Clinic at the Hospital das Clínicas of UNICAMP diagnosed with keratoconus who are indicated for crosslinking will be evaluated regarding visual acuity, refraction, biomic...
Eligibility Criteria
Inclusion
- Patients with a diagnosis of keratoconus, indicated for corneal crosslinking
Exclusion
- Diabetes Mellitus
- Severe dry eye
- Limbal Stem Cell Deficiency
- Glaucoma
- Insulin or methylcellulose allergy
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2025
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT06601101
Start Date
August 1 2024
End Date
October 1 2025
Last Update
January 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
State University of Campinas
Campinas, São Paulo, Brazil, 13.083-887